Literature DB >> 4418334

The chemotherapy of large-bowel cancer. Present status and future prospects.

J Horton, C B Hacker, T J Cunningham, R W Sponzo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4418334     DOI: 10.1007/BF01255788

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


× No keyword cloud information.
  31 in total

1.  Transplantation of chemically induced metastatic mucinous adenocarcinomas of the jejunum and colon in rats.

Authors:  J M Ward; R S Yamamoto; J H Weisburger; T Benjamin
Journal:  J Natl Cancer Inst       Date:  1973-12       Impact factor: 13.506

Review 2.  The use of drugs in combination for the treatment of cancer: rationale and results.

Authors:  V T DeVita; P S Schein
Journal:  N Engl J Med       Date:  1973-05-10       Impact factor: 91.245

3.  Fluorouracil as an adjuvant to surgery in carcinoma of the colon.

Authors:  G A Higgins; R W Dwight; J V Smith; R J Keehn
Journal:  Arch Surg       Date:  1971-04

4.  Single versus multiple dose dactinomycin therapy of Wilms's tumor. A controlled co-operative study conducted by the Children's Cancer Study Group A (formerly Acute Leukemia Co-operative Chemotherapy Group A).

Authors:  J A Wolff; W A Newton; W Krivit; G J D'Angio
Journal:  N Engl J Med       Date:  1968-08-08       Impact factor: 91.245

5.  Comparative response of carcinoma of the rectum and carcinoma of the colon to fluorinated pyrimidine therapy.

Authors:  C G Moertel; R J Reitemeier; R G Hahn
Journal:  Cancer Chemother Rep       Date:  1969-10

6.  Carcinoembryonic antigen present in human colonic neoplasms serially propagated in hamsters.

Authors:  D M Goldenberg; H J Hansen
Journal:  Science       Date:  1972-03-10       Impact factor: 47.728

7.  Intraluminal chemotherapy (HN2 or 5-FU) adjuvant to operation for cancer of the colon and rectum. II. Follow-up report of 97 cases.

Authors:  L M Rousselot; D R Cole; C E Grossi; A J Conte; E M Gonzalez
Journal:  Cancer       Date:  1967-05       Impact factor: 6.860

8.  Comparison of a combination of 5-fluorouracil (NSC-19893), mitomycin C (NSC-26980), triethylenethiophosphoramide (NSC-6396), and fluoxymesterone (NSC-12165) with 5-fluorouracil alone in patients with advanced cancer.

Authors:  J Horton; K B Olson; T Cunningham; J Sullivan
Journal:  Cancer Chemother Rep       Date:  1968-09

9.  Phase I study of 5-azacytidine (NSC-102816) .

Authors:  A J Weiss; J E Stambaugh; M J Mastrangelo; J F Laucius; R E Bellet
Journal:  Cancer Chemother Rep       Date:  1972-06

10.  Combination therapy with mitomycin C (NSC-26980), 5-fluorouracil (NSC-19893), and cytosine arabinoside (NSC-63878) for advanced cancer in man.

Authors:  K Ota; S Kurita; M Nishimura; M Ogawa; Y Kamei; K Imai; Y Ariyoshi; K Kataoka; M Murakami; A Oyama; A Hoshino; H Amo; T Kato
Journal:  Cancer Chemother Rep       Date:  1972-06
View more
  2 in total

1.  Carcinoma of the colon and rectum. A perspective for practicing physicians, with recommendations for screening.

Authors:  T M Dean
Journal:  West J Med       Date:  1977-06

2.  Combined adjuvant therapy of radically operated colorectal cancer patients. (chemotherapy, radiotherapy, and MER-BCG).

Authors:  E Robinson; A Bartal; Y Cohen; N Haim; J Mohilever; T Mekori
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.